Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes

Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):28-40. doi: 10.1161/01.ATV.0000191663.12164.77. Epub 2005 Oct 20.

Abstract

Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors belonging to the nuclear hormone receptor superfamily. The 3 PPAR isotypes, PPAR-alpha, PPAR-gamma, and PPAR-delta, play a key role in the regulation of lipid and glucose metabolism. Obesity and the interrelated disorders of the metabolic syndrome have become a major worldwide health problem. In this review, we summarize the critical role of PPARs in regulating inflammation, lipoprotein metabolism, and glucose homeostasis and their potential implications for the treatment of obesity, diabetes, and atherosclerosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Atherosclerosis / complications
  • Atherosclerosis / metabolism*
  • Atherosclerosis / therapy
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / metabolism*
  • Diabetes Mellitus, Type 2 / therapy
  • Humans
  • Obesity / complications
  • Obesity / metabolism*
  • Obesity / therapy
  • Peroxisome Proliferator-Activated Receptors / metabolism*

Substances

  • Peroxisome Proliferator-Activated Receptors